Not Signed In -
Rivastigmine Oral Solution |
Exelon Oral Solution |
Clinical Trial: Efficacy and Safety of Rivastigmine Capsules in Patients with Probable Vascular Dementia
This study is currently recruiting patients.
|
Purpose
The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Vascular Dementia | Drug: Rivastigmine | Phase III |
MedlinePlus related topics: Dementia; Stroke; Vascular Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Study start: July 2001
Eligibility
Ages Eligible for Study: 50 Years - 85 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Between the ages of 50 and 85 years old
- Have contact with a responsible caregiver 3 or more days per week
- Be male or a female who is surgically sterilized or one year post menopausal
Exclusion Criteria:
- Current diagnosis of severe or unstable cardiovascular or other diseases
- Current diagnosis of active, uncontrolled seizure disorder, Parkinson’s disease or Alzheimer's disease
Location and Contact Information
Please email or see link below for contact information ENA.713@pharma.novartis.com
California
Irvine, California, 92618, United States; Recruiting
San Francisco, California, 94109, United States; Recruiting
Florida
Boynton Beach, Florida, 33426, United States; Recruiting
Miami Beach, Florida, 33140, United States; Recruiting
Port Charlotte, Florida, United States; Recruiting
Indiana
Indianapolis, Indiana, 46202, United States; Recruiting
Iowa
Des Moines, Iowa, 50314, United States; Recruiting
Missouri
St. Louis, Missouri, United States; Recruiting
New Mexico
Albuquerque, New Mexico, United States; Recruiting
New York
New York, New York, 10003, United States; Recruiting
Oregon
Portland, Oregon, 97223, United States; Recruiting
Pennsylvania
Greensburg, Pennsylvania, 15601, United States; Recruiting
Allentown, Pennsylvania, 18103, United States; Recruiting
South Carolina
Charleston, South Carolina, 29406, United States; Recruiting
Texas
Houston, Texas, 77030, United States; Recruiting
Austin, Texas, 78756, United States; Recruiting
Vermont
Bennington, Vermont, 05201, United States; Recruiting
Austria
Graz, Austria; Recruiting
Linz, Austria; Recruiting
Wien, Austria; Recruiting
Canada, Alberta
Edmonton, Alberta, Canada; Recruiting
Canada, Ontario
Toronto, Ontario, Canada; Recruiting
Ottawa, Ontario, Canada; Recruiting
Canada, Quebec
Montreal, Quebec, Canada; Recruiting
France
Bordeaux, France; Recruiting
Montpellier Cedex, France; Recruiting
Lille Cedex, France; Recruiting
Toulouse, France; Recruiting
Tours Cedex, France; Recruiting
Marseille, France; Recruiting
Amiens, France; Recruiting
Germany
Freiburg, Germany; Recruiting
Chemnitz, Germany; Recruiting
Erlangen, Germany; Recruiting
Berlin, Germany; Recruiting
LUEDENSCHEID, Germany; Recruiting
Eisenhuttenstadt, Germany; Recruiting
Bochum, Germany; Recruiting
Bautzen, Germany; Recruiting
Osnabrueck, Germany; Recruiting
Italy
Ancona, Italy; Recruiting
Brescia, Italy; Recruiting
Firenze, Italy; Recruiting
Perugia, Italy; Recruiting
Roma, Italy; Recruiting
Vicenza, Italy; Recruiting
Reggio Emilia, Italy; Recruiting
Russian Federation
Moscow, Russian Federation; Recruiting
Saint Petersburg, Russian Federation; Recruiting
Spain
Barcelona, Spain; Recruiting
Pamplona, Spain; Recruiting
Saint Cugat del Valles, Spain; Recruiting
Barakaldo, Spain; Recruiting
Madrid, Spain; Recruiting
Switzerland
Basel, Switzerland; Recruiting
Lausanne, Switzerland; Recruiting
United Kingdom
Southampton, United Kingdom; Recruiting
Bristol, United Kingdom; Recruiting
Clydebank, United Kingdom; Recruiting
East Sussex, United Kingdom; Recruiting
St Annes, United Kingdom; Recruiting
United Kingdom, Newcastle
Newcastle upon Tyne, Newcastle, United Kingdom; Recruiting
United Kingdom, Wiltshire
Swindon, Wiltshire, United Kingdom; Recruiting
More Information
Click here for further information and to find an investigational site near you
Study ID Numbers: CENA713BIA05
Record last reviewed: December 2004
Last Updated: December 9, 2004
Record first received: December 9, 2004
ClinicalTrials.gov Identifier: NCT00099216
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: December 2004
Last Updated: December 9, 2004
Record first received: December 9, 2004
ClinicalTrials.gov Identifier: NCT00099216
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Exelon Oral Solution (Drug Digest)
- Rivastigmine Oral Solution (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
